Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03420430
Title Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Genelux Corporation
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

GL-ONC1

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.